<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        19-968-16
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2016
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        LEVON 750 mg film-coated tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LEVOFLOXACIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        750
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        58.25
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="DAMMAM PHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            DAMMAM PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 718]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ARAC HEALTHCARE
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            DAMMAM PHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01MA12
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Levon Tablet contains a drug called levofloxacin. Levofloxacin is an antibiotic which is used to treat bacterial infections of the</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sinuses</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; lungs, in people with long-term breathing problems or Pneumonia</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; urinary tract, including your kidneys or bladder</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; prostate gland, where you have a long lasting infection</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin and underneath the skin, including muscles. This is sometimes called &lsquo;soft tissue&rsquo;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In some special situations, Levon Tablets may be used to lessen the chances of getting a pulmonary disease named anthrax or worsening of the disease after you are exposed to the bacteria causing anthrax.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Levon Tablets and tell your doctor if:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are allergic to levofloxacin, any other quinolone antibiotic such as moxifloxacin, ciprofloxacin or ofloxacin or to any of the other ingredients of this medicine (listed in section6). Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If your eyesight becomes impaired or if your eyes seem to be otherwise affected, consult an eye specialist immediately.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have ever had epilepsy</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have ever had a problem with your tendons such as tendonitis that was related to treatment with a &lsquo;quinolone antibiotic&#39;. A tendon is the cord that joins your muscle to your skeleton.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are a child or a growing teenager</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are pregnant, trying to become pregnant or are breast-feeding.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not take this medicine if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking Levon Tablets.</p><p><strong>Warnings and precautions</strong></p><p><strong>Talk to your doctor or pharmacist before taking Levon Tablets if:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have been diagnosed with an enlargement or &ldquo;bulge&rdquo; of a large blood vessel (aortic aneurysm or large vessel peripheral aneurysm).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have experienced a previous episode of aortic dissection (a tear in the aorta wall).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have a family history of aortic aneurysm or aortic dissection or other risk factors or predisposing conditions (e.g. connective tissue disorders such as Marfan syndrome, or vascular Ehlers-Danlos syndrome, or vascular disorders such as Takayasu arteritis, giant cell arteritis, Behcet`s disease, high blood pressure, or known atherosclerosis).</p><p>&nbsp;</p><p>If you feel sudden, severe pain in your abdomen, chest, or back, go immediately to an emergency room.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are 60 years of age or older.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are using corticosteroids, sometimes called steroids (see section &ldquo;Other medicines and Levon Tablets&rdquo;).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have ever had a fit (seizure).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have had damage to your brain due to a stroke or other brain injury.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have kidney problems.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have something known as &lsquo;glucose &ndash; 6 &ndash; phosphate dehydrogenase deficiency&rsquo;. You are more likely to have serious problems with your blood when taking this medicine.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have ever had mental health problems (as all fluoroquinolones may cause mental health changes such as disturbances in attention, disorientation, agitation, nervousness, memory impairment and delirium).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have ever had Heart problems:Caution should be taken when using this kind of medicine, if you were born with or have family history of prolonged QT interval (seen onECG, electrical recording of the heart), have salt imbalance in the blood (especially low level of potassium or magnesium in the blood), have a very slow heart rhythm (called &lsquo;bradycardia&rsquo;), have a weak heart (heart failure), have a history of heart attack (myocardial infarction), you are female or elderly or you are taking other medicines that result in abnormal ECG changes (see section <em>Other medicines and Levon Tablets</em>).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You are diabetic (Hypoglycemia - including hypoglycemic coma- has been reported. If this happens, contact your doctor immediately.)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have ever had liver problems</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have myasthenia gravis.</p><p><strong>Other warnings</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Levofloxacin may rarely cause pain and inflammation in tendons. Particularly if you are elderly or are taking steroid medicines (such as cortisone or hydrocortisone). If you have any problems with your tendons whilst or shortly after taking levofloxacin, seek medical advice atonce and rest the affected limb (leg or arm). Do not take the next dose of levofloxacin unless your doctor tells you to. In such as cases, you experience swelling or pain in the area of affected tendon. It may be necessary to stop treatment</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you start having severe, persistent and/or bloody diarrhoea during or after treatment with levofloxacin, tell your doctor immediately. This could mean you have serious inflammation of your bowel (pseudomembranous colitis), which can sometimes occur after antibiotic treatment.You may need to stop taking levofloxacin and for your doctor to give you another medicine.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Whilst taking Levon Tablets you are advised to stay out of strong sunlight and not to use a sun lamp. This is because some patients may become more sensitive to light whilst taking the tablets and get a sun-burn like reaction.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Levofloxacin should be discontinued if the patient experiences symptoms Burning, tingling, pain or numbness. These may be signs of something called &lsquo;neuropathy&rsquo;.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Levofloxacin is not an optimal therapy for most severe cases of Pneumococcal pneumonia.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Infections got from a hospital during treatment due to P.aeruginosa may require combination therapy.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Levofloxacin is not effective against infections caused by MRSA. In infections suspicious forMRSA levofloxacin should be combined with an agent approved to treat MRSA infections.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p><p>If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before taking Levon Tablets.</p><p><strong>Other medicines and Levon Tablets</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This is because Levon Tablets can affect the way some other medicines work. Also some medicines can affect the way Levon Tablets work.</p><p><strong>In particular, tell your doctor if you are taking any of the following medicines. This is because it can increase the chance of you getting side effects, when taken with Levon Tablets</strong>:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corticosteroids, sometimes called steroids &ndash; used for inflammation. You may be more likely to have inflammation and/or rupture of your tendons.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Warfarin - used to thin the blood. You may be more likely to have a bleed. Your doctor may need to take regular blood tests to check how well your blood can clot.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Theophylline - used for breathing problems. You are more likely to have a fit (seizure) if taken with Levon Tablets</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-steroidal anti-inflammatory drugs (NSAIDS) - used for pain and inflammation such as aspirin, ibuprofen, fenbufen, ketoprofen and indomethacin. You are more likely to have a fit (seizure) if taken with Levon Tablets</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ciclosporin - used after organ transplants. You may be more likely to get the side effects of ciclosporin</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines known to affect the way your heart beats. This includes medicines used for abnormal heart rhythm (antiarrhythmics such as quinidine, hydroquinidine, disopyramide, sotalol, dofetilide, ibutilide and amiodarone), for depression (tricyclic antidepressants such as amitriptyline and imipramine), for psychiatric disorders (antipsychotics), and for bacterial infections (&lsquo;macrolide&rsquo; antibiotics such as erythromycin, azithromycin and clarithromycin)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Probenecid &ndash; used for gout and cimetidine &ndash; used for ulcers and heartburn. Special care should be taken when taking either of these medicines with Levon Tablets. If you have kidney problems, your doctor may want to give you a lower dose.</p><p><strong>Do not take Levon Tablets at the same time as the following medicines. This is because it can affect the way Levon Tablets work:</strong></p><p>&middot;&nbsp;&nbsp; Iron tablets (for anemia), zinc supplements, magnesium or aluminum-containing antacids (for acid or heartburn), didanosine, or sucralfate (for stomach ulcers). See section 3 &ldquo;If you are already taking iron tablets, zinc supplements, antacids, didanosine or sucralfate&rdquo; below.</p><p><strong>Urine tests for opiates</strong></p><p>Urine tests may show &lsquo;false-positive&rsquo; results for strong painkillers called &lsquo;opiates&rsquo; in people takingLevon Tablets. If your doctor is due to take a urine test, tell them you are taking Levon Tablets.</p><p><strong>Tuberculosis tests</strong></p><p>This medicine may cause &ldquo;false negative&rdquo; results for some tests used in laboratory to search for thebacteria causing tuberculosis.</p><p><strong>Taking Levon Tablets with food and drink</strong></p><p>Take without regard to meals. Take with water, drink with plenty of water. Taking this product with orange juice can result in reduced quinolone plasma levels.</p><p><strong>Pregnancy and breast-feeding</strong></p><p>You must not take Levon Tablets if you are pregnant, trying to become pregnant or are breastfeeding.</p><p><strong>Driving and using machines</strong></p><p>You may get side effects after taking this medicine, including feeling dizzy, sleepy, a spinning feeling (vertigo) or changes to your eyesight. Some of these side effects can affect you being able to concentrate and your reaction speed. If this happens, do not drive or carry out any work that requires a high level of attention.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take <strong>Levon Tablets</strong>exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p><strong>Taking this medicine</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Take this medicine by mouth</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swallow the tablets whole with a drink of water</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The tablets may be taken during meals or at any time between meals</p><p><strong>Protect your skin from sunlight</strong></p><p>Keep out of direct sunlight while taking this medicine and for 2 days after you stop taking it. This is because your skin will become much more sensitive to the sun and may burn, tingle or severely blister if you do not take the following precautions:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Make sure you use high factor sun cream</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Always wear a hat and clothes which cover your arms and legs</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Avoid sun beds</p><p><strong>If you are already taking iron tablets, zinc supplements, antacids, didanosine or sucralfate</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not take these medicines at the same time as Levon Tablets. Take your dose of these medicines at least 2 hours before or after Levon Tablets.</p><p><strong>How much to take</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your doctor will decide on how many Levon Tablets you should take</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The dose will depend on the type of infection you have and where the infection is in your body.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The length of your treatment will depend on how serious your infection is.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you feel the effect of your medicine is too weak or strong, do not change the dose yourself, but ask your doctor.</p><p><strong>Adults and the elderly</strong></p><p><strong>Acute Bacterial Sinuses:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 500 mg , once each day for 10-14 .</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 750 mg , once each day for 5 days.</p><p><strong>Pneumonia:</strong></p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nosocomial Pneumonia:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 750 mg, once each dayfor 7-14 days<strong>.</strong></p><p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Community Acquired Pneumonia:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 500 mg , once each day for 10-14&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 750 mg , once each day for 5 days.</p><p><strong>Acute bacterial exacerbation of chronic bronchitis:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 500 mg , once each day for 7 days.</p><p><strong>Complicated urinary tract infection or acute pyelonephritis;</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 750 mg, each dayfor 5 days.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 250 mg, each dayfor 10 days.</p><p><strong>Uncomplicated urinary tract infection:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 250 mg, each dayfor 3 days<strong>.</strong></p><p><strong>Chronic bacterial Prostatitis.</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 500 mg, once each day for 28 days.</p><p><strong>Complicated skin and skin structure infections (SSSI):</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 750 mg, once each dayfor 7-14 days.</p><p><strong>Uncomplicated (SSSI):</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 500 mg, once each day for 7-10 days.</p><p><strong>Adults and the elderly with kidney problems</strong></p><p>Your doctor may need to give you a lower dose.</p><p><strong>Children and adolescents</strong></p><p>This medicine must not be given to children or teenagers.</p><p><strong>If you take more Levon Tablets than you should</strong></p><p>If you accidentally take more tablets than you should, tell a doctor or get other medical advice straight away. Take the medicine pack with you. This is so the doctor knows what you have taken. The following effects may happen: convulsive fits (seizures), feeling confused, dizzy, less conscious, having tremor and heart problems - leading to uneven heart beats as well as feeling sick (nausea) or having stomach burning.</p><p><strong>If you forget to take a dose of Levon Tablets</strong></p><p>If you forget to take a dose, take it as soon as you remember unless it is nearly time for your next dose.</p><p>Do not double-up the next dose to make up for the missed dose.</p><p><strong>If you stop taking Levon Tablets</strong></p><p><strong>Do not stop taking Levon Tablets just because you feel better. </strong>It is important <strong>that you complete </strong>the course of tablets <strong>that your doctor has prescribed for you. If you </strong>stop taking the tabletstoo soon, the infection may <strong>return, your condition may </strong>get worse <strong>or the bacteria may become resistant to </strong>the <strong>medicine</strong>.</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. These effects are normally mild or moderate and often disappear after a short time.</p><p><strong>Stop taking Levon Tablets and see a doctor or go to a hospital straight away if </strong>you <strong>notice the following side effect:</strong></p><p><strong>Rare</strong>(may affect up to 1 in 1000 people)</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You have an allergic reaction. The signs may include: a rash, swallowing or breathing problems, swelling of your lips, face, throat, or tongue, rapid decrease in blood pressure (with symptoms such as shallow breathing, dizziness and weak pulse)</p><p>&nbsp;</p><p>Stop taking Levon Tablets and see a doctor straight away if you notice <strong>any of the following </strong>serious side <strong>effects </strong>- you may need urgent medical treatment:</p><p><strong>Rare </strong>(may affect up to 1 in 1,000 people)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain and inflammation in your tendons or ligaments, which could lead to rupture. The Achilles tendon is affected most often</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fits (convulsions)</p><p>&nbsp;</p><p><strong>Not known </strong>(frequency cannot be estimated from the available data)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe skin rashes which may include blistering or peeling of the skin around your lips, eyes, mouth, nose and genitals or a rash with round measles-like patches, fever and joint pains</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in your opinion and thoughts with a risk of having suicidal thoughts or actions.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of appetite, nausea, vomiting, skin and eyes becoming yellow in colour, dark-coloured urine, fever, itching, or tender stomach (abdomen). These may be signs of liver problems which may include a fatal failure of the liver.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Watery diarrhoea which may have blood in it, possibly with stomach cramps and a high temperature. These could be signs of a severe bowel problem.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abnormal fast heart rhythm, life-threatening irregular heart rhythm including cardiac arrest, alteration of the heart rhythm (called &lsquo;prolongation of QT interval&rsquo;, seen on ECG, electrical activity of the heart).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Burning, tingling, pain or numbness. These may be signs of something called &lsquo;neuropathy&rsquo;.</p><p>&nbsp;</p><p>If your eyesight becomes impaired or if you have any other eye disturbances whilst taking Levofloxacin, consult an eye specialist immediately.</p><p>&nbsp;</p><p><strong>Tell your doctor if any of the following side effects </strong>gets serious <strong>or </strong>lasts longer than a few days:</p><p><strong>Common </strong>(may affect up to 1 in 10 people)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sleeping problems</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache, feeling dizzy</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling sick (nausea, vomiting) and diarrhoea</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in the level of some liver enzymes in your blood</p><p><strong>Uncommon </strong>(may affect up to 1 in 100 people)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the number of other bacteria or fungi, infection by fungi named Candida, which may need to be treated</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the number of white blood cells shown up in the results of some blood tests (leukopenia, eosinophilia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling stressed (anxiety), feeling confused, feeling nervous, feeling sleepy, trembling, a spinning feeling (vertigo)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shortness of breath (dyspnoea)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the way things taste, loss of appetite, stomach upset or indigestion (dyspepsia), pain in your stomach area, feeling bloated (flatulence) or constipation</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Itching and skin rash, severe itching or hives (urticaria), sweating too much (hyperhidrosis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Joint pain or muscle pain</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood tests may show unusual results due to liver (bilirubin increased) or kidney(creatinine increased) problems</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; General weakness</p><p><strong>Rare </strong>(may affect up to 1 in 1,000 people)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bruising and bleeding easily due to a lowering in the number of blood platelets (thrombocytopenia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low number of white blood cells (neutropenia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exaggerated immune response (hypersensitivity)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lowering of your blood sugar levels (hypoglycaemia). This is important for people that have diabetes.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes to your mental health such as Seeing or hearing things that are not there (hallucinations, paranoia), change in your opinion and thoughts (psychotic reactions) with a risk of having suicidal thoughts or actions</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling depressed, mental problems, feeling restless (agitation), abnormal dreams or nightmares</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tingly feeling in your hands and feet (paraesthesia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Problems with your hearing (tinnitus) or eyesight (blurred vision)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unusual fast beating of your heart (tachycardia) or low blood pressure (hypotension)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle weakness. This is important in people with myasthenia gravis (a <strong>rare </strong>disease of the nervous system).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the way your kidney works <strong>and </strong>occasional kidney failure which may <strong>be </strong>due to an allergic kidney reaction called interstitial nephritis.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever</p><p><strong>Not known</strong> (frequency cannot be estimated from the available data):</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lowering in red blood cells (anemia): this can make the skin pale or yellow due to damage of the red blood cells; lowering in the number of all types of blood cells (pancytopenia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever, sore throat and a general feeling of being unwell that does not go away. This may be due to a lowering in the number of white blood cells (agranulocytosis).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase of your blood sugar levels (hyperglycaemia) or lowering of your blood sugar levels leading to coma (hypoglycaemic coma). This is important for people that have diabetes.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the way things smell, loss of smell or taste (parosmia, anosmia, ageusia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Problems moving and walking (dyskinesia, extrapyramidal disorders)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Temporary loss of consciousness or posture (syncope)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Temporary loss of vision, inflammation of the eye</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Impairment or loss of hearing</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Difficulty breathing or wheezing (bronchospasm)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic lung reactions</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain in the upper abdomen and back, feeling or being sick which may be caused by inflammation of pancreas (pancreatitis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased sensitivity of your skin to sun and ultraviolet light (photosensitivity)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the vessels that carry blood around your body due to an allergic reaction (vasculitis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the tissue inside the mouth (stomatitis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle rupture and muscle destruction (rhabdomyolysis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Joint redness and swelling (arthritis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain, including pain in the back, chest and extremities</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Attacks of porphyria in people who already have porphyria (a very rare metabolic disease)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Persistent headache with or without blurred vision (benign intracranial hypertension)</p><p><strong>&nbsp;</strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep this medicine out of the sight and reach of children.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store above 30&deg;C.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this medicine after the expiry date which is stated on the carton and blister strip afterEXP. The expiry date refers to the last day of that month.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how tothrow away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is levofloxacin.</p><p>Each film coated tablet of <strong>Levon </strong>250 mg film coated tablets contains 250 mg of levofloxacin, each film coated tablet of <strong>Levon </strong>500 mg film coated tablets contains 500 mg of levofloxacin and each film coated tablet of <strong>Levon </strong>750 mg film coated tablets contains 750 mg of levofloxacin.</p><p>&nbsp;</p><p>Excipients for core: Hydroxypropyl methylcellulose EP, crospovidone NF, silicified microcrystalline cellulose, and magnesium stearate.</p><p>&nbsp;</p><p>Excipients for film coating: Polysorbate 80 EP, titanium dioxide EP, purified talc EP, polyethylene glycol MW 6000 EP, hydroxypropyl methylcellulose EP, iron oxide yellow.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Levon 250mg tablets are film-coated tablets for oral use. The tablets are oblong with light yellow colour.

Levon 500mg tablets are yellow, oblong, biconvex film coated tablets engraved with a “T211” on one side and a plain surface on the other side.

Levon 750mg tablets are yellow, oblong, biconvex film coated tablets engraved with a “T212” on one side and a plain surface on the other side.

Levon 250, 500, and 750 mg are available in pack sizes of 5 tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Dammam Pharma</p><p>Saudi Arabia</p><p>Address: 1st industrial city, unit No.1, PO.BOX: 7137, Dammam 32234-4384</p><p>Phone: +966138216444</p><p>Fax: +966138216422</p><p>Email: regulatory-affairs@dammampharma.sa</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                November 2018.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي&nbsp;قرص ليفون&nbsp;على مادة فعالة تسمى&nbsp;ليفوفلوكساسين&nbsp;.&nbsp;ليفوفلوكساسين&nbsp;هو مضاد حيوي يستخدم لعلاج الالتهابات البكتيرية في:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجيوب الأنفية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرئتين، في الأشخاص الذين يعانون من مشاكل في التنفس على المدى الطويل أو الالتهاب الرئوي</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المسالك البولية، بما في ذلك الكلى أو المثانة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; غدة البروستاتا ، إذا كان لديك عدوى طويلة الأمد</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجلد&nbsp;وتحت الجلد، بما في ذلك العضلات.&nbsp;هذا يسمى أحيانا &quot;الأنسجة اللينة&quot;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في بعض الحالات الخاصة ،&nbsp;قد تستخدم&nbsp;أقراص&nbsp;ليفون&nbsp;لتقليل فرص الإصابة بمرض رئوي يسمى الجمرة الخبيثة أو تفاقم المرض بعد تعرضك للبكتيريا المسببة للجمرة الخبيثة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول</strong>&nbsp;<strong>أقراص</strong>&nbsp;<strong>ليفون وأخبر طبيبك إذا:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان&nbsp;لديك حساسية&nbsp;لليفوفلوكساسين&nbsp;، أو أي&nbsp;مضاد حيوي&nbsp;آخر من&nbsp;مجموعة الكينولون&nbsp;مثل&nbsp;موكسيفلوكساسين&nbsp;، سيبروفلوكساسين أو&nbsp;أوفلوكساسين&nbsp;أو لأي من المكونات الأخرى لهذا الدواء (مدرجة في القسم&nbsp;6).&nbsp;تتضمن علامات الحساسية ما يلي: طفح جلدي ، مشاكل في البلع أو التنفس ، تورم شفاهك ، وجهك ، حلقك أو لسانك.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا أصبح بصرك ضعيفًا أو إذا تأثرت عيناك بأي شكل، فاستشر أخصائي العيون على الفور.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت قد أصبت بالصرع</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت قد عانيت من أي وقت مضى من مشكلة في الأوتار مثل التهاب الأوتار أثناءالعلاج&nbsp;بمضاد حيوي &quot;&nbsp;كينولون&nbsp;&quot;.&nbsp;الوتر هو الحبل الذي يربط عضلاتك بالهيكل العظمي.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت طفل أو في مرحلة المراهقة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت حامل أوتخططين للحمل أو الرضاعة الطبيعية.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتناول هذا الدواء إذا كان أي مما سبق ينطبق عليك.&nbsp;إذا كنت غير متأكد ، تحدث إلى طبيبك أو الصيدلي قبل تناول&nbsp;أقراص&nbsp;ليفون&nbsp;.</p><p dir="RTL"><strong>المحاذير والاحتياطات</strong></p><p dir="RTL"><strong>تحدث إلى طبيبك أو الصيدلي قبل تناول</strong>&nbsp;<strong>أقراص</strong>&nbsp;<strong>ليفون</strong>&nbsp;<strong>إذا:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تم تشخيصك بتضخم أو &quot;انتفاخ&quot; في وعاء دموي كبير (تمدد فى وعاء الأبهر (الأورطى) أو تمدد الأوعية الدموية المحيطية الكبيرة).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تعرضت مسبقاً لحالة تمزق في جدار الأورطى.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك تاريخ عائلي من تمدد الأوعية الدموية الأبهري (الأورطى) أو تمزق في جدار الأورطى أو عوامل خطر أخرى أو حالات مهيئة (مثل اضطرابات الأنسجة الضامة مثل متلازمة مارفان أو متلازمة الأيلاروس - دانلوس الوعائية, أو اضطرابات الأوعية الدموية مثل التهاب الشرايين التاكاياسو, أو التهاب شرايين الخلايا الكبرى, مرض بهسيت وارتفاع ضغط الدم, أو تصلب الشرايين).</p><p dir="RTL">إذا شعرت بألم شديد مفاجئ في بطنك أو صدرك أو ظهرك, فتوجه فوراً إلى غرفة الطوارئ.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان عمرك 60 سنة أو أكبر.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تستخدم الكورتيكوستيرويدات ، التي تسمى أحيانًا الستيرويدات (انظر القسم &quot;أدوية أخرى&nbsp;وأقراص&nbsp;ليفون&nbsp;&quot;).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك من أي وقت مضى تشنجات (نوبات).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك خللفيدماغك بسبب سكتة دماغية أو إصابة دماغية أخرى.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك مشاكل في الكلى.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك شيء يعرف باسم &quot; نقص إنزيم الجلوكوز - 6 -&nbsp;فوسفات&nbsp;ديهيدروجينيز&nbsp;&quot;.&nbsp;فأنت أكثر عرضة لمشاكل خطيرة في دمك عند تناول هذا الدواء.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك من أي وقت مضى مشاكل في الصحة العقلية&nbsp;(حيث أن كل&nbsp;الفلوروكينولونات&nbsp;قد تسبب تغيرات في الصحة العقلية مثل&nbsp;الاضطرابات في الانتباه ، والتوهان ، والإرتباك ، والعصبية ،&nbsp;وضعف الذاكرة والهذيان)&nbsp;.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك من أي وقت مضى مشاكل في القلب:&nbsp;يجب توخي الحذر عند استخدام هذا النوع من الأدوية ، إذا كنت قد ولدت أو لديك تاريخ عائلي لزيادة فترةQT تظهر في رسم القلب.(تخطيط القلب الكهربائي ، والتسجيل الكهربائي للقلب) ، أو كان لديك خلل في توازن الأملاح في الدم (خاصة انخفاض مستوى البوتاسيوم أو المغنيسيوم في الدم) ، أو كان معدل ضربات القلب بطيئًا جدًا (يطلق عليه &quot;&nbsp;بطء القلب&nbsp;&quot;) ، أو القلب ضعيفًا (فشل القلب) ، أو إذا كان لديك تاريخ من النوبات القلبية (احتشاء عضلة القلب) ، أو كنت أنثى أو مسن أو كنت تتناول أدوية أخرى ينتج عنها تغيرات غير طبيعية في تخطيط القلب (انظر قسم&nbsp;أدوية أخرى&nbsp;وأقراص&nbsp;ليفون&nbsp;).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت مريض بالسكر&nbsp;(تمالإبلاغعننقصالسكرفيالدم - بمافيذلكغيبوبةسكرالدم. إذاحدثهذا،اتصلبطبيبكعلىالفور.)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك من أي وقت مضى مشاكل في الكبد</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك الوهن العضلي الوبيل.</p><p dir="RTL"><strong>تحذيرات أخرى</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نادرا ما يسبب&nbsp;الليفوفلوكساسين&nbsp;الألم والالتهاب في الأوتار.&nbsp;خاصة إذا كنت من كبار السن أو تتناول أدوية الستيرويد (مثل الكورتيزون أو الهيدروكورتيزون).&nbsp;إذا كان لديك أي مشاكل في الأوتار أثناء أو بعد وقت قصير منتناول&nbsp;الليفوفلوكساسين، اطلب المشورة الطبية فورا وقم بإراحة الطرف المصاب (الساق أو الذراع).&nbsp;لا تتناول الجرعةالتالية منالليفوفلوكساسين&nbsp;ما لم يخبرك طبيبك بذلك.&nbsp;في مثل هذه الحالات، قدتعاني من التورم أو الألم في منطقة الوتر المصاب.&nbsp;قد يكون من الضروري التوقف عن العلاج</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا بدأت تعاني من الإسهال الشديد والمستمر و / أو الدموي أثناء أو بعد العلاج&nbsp;بالليفوفلوكساسين&nbsp;، أخبر طبيبك على الفور.&nbsp;هذا قد يعني أنك تعاني من التهاب خطير في الأمعاء (&nbsp;التهاب&nbsp;القولون&nbsp;الكاذب&nbsp;) ، والذي يمكن أن يحدث في بعض الأحيان بعد العلاج بالمضادات الحيوية.&nbsp;قد تحتاج إلى التوقف عن تناول&nbsp;الليفوفلوكساسين&nbsp;وقد يعطيك الطبيب دواء آخر.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أثناء تناول&nbsp;أقراص&nbsp;ليفون، ننصحك بالابتعاد عن أشعة الشمس القوية وعدم استخدام مصباح الشمس.&nbsp;وذلك لأن بعض المرضى قد يصبحون أكثر حساسية للضوء بينما يتناولون الأقراص ويتعرضونلرد فعل تحسسي يشبه حرقة الشمس.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب إيقاف&nbsp;الليفوفلوكساسين&nbsp;إذا كان المريض يعاني من أعراض الشعوربالحرق أو الوخز أو الألم أو التنميل.&nbsp;قد تكون هذه علامات على شيء يسمى &quot;الاعتلال العصبي&quot;.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ليفوفلوكساسين&nbsp;ليس العلاج الأمثل لمعظم الحالات الشديدة من الالتهاب الرئوي.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عند تعرضك للعدوى من مستشفى أثناء العلاج بسبب&nbsp;P.aeruginosa&nbsp;قد تتطلب علاج إضافي.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ليفوفلوكساسين&nbsp;ليس فعال ضد الالتهابات التي تسببها MRSA.&nbsp;أو في الالتهابات التي يحتمل أن تكون بسبب MRSA.يجب أن يقترن&nbsp;الليفوفلوكساسين&nbsp;مع دواء معتمد لعلاج عدوى MRSA.&nbsp;&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا لم تكن متأكدًا مما إذا كان أي مما سبق ينطبق عليك ، تحدث إلى طبيبك أو الصيدلي قبلتناول&nbsp;أقراص&nbsp;ليفون&nbsp;أقراص&nbsp;.</p><p dir="RTL"><strong>أدوية أخرى</strong>&nbsp;<strong>وأقراص</strong>&nbsp;<strong>ليفون</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أخبر طبيبك أو الصيدلي إذا كنت تتناول، أو تناولت مؤخرا أو قد تتناول أي أدوية أخرى.&nbsp;وذلك لأن&nbsp;أقراص&nbsp;ليفون&nbsp;يمكن أن تؤثر على طريقة عمل بعض الأدوية الأخرى.&nbsp;أيضا بعض الأدوية يمكن أن تؤثر على طريقة&nbsp;عمل&nbsp;أقراص ليفون&nbsp;.</p><p dir="RTL"><strong>على وجه الخصوص، أخبر طبيبك إذا كنت تتناول أي من الأدوية التالية.</strong>&nbsp;<strong>هذا لأنه يمكن أن يزيد من فرص حدوثأعراض جانبية ، عند تناول</strong>&nbsp;<strong>أقراص</strong>&nbsp;<strong>ليفون</strong>&nbsp;:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الكورتيكوستيرويدات ، التي تسمى أحيانا الستيرويدات - تستخدم لعلاج الالتهاب.&nbsp;قد تكون أكثر عرضة للالتهاب و / أو تمزق الأوتار الخاصة بك.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الوارفارين&nbsp;- يستخدم لزيادة سيولة الدم.&nbsp;قد تكون أكثر عرضة لحدوث نزيف.&nbsp;قد يحتاج طبيبك لإجراء فحوصات دم منتظمة للتحقق من مدى درجة تجلط الدم لديك.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الثيوفيلين&nbsp;- يستخدم لمشاكل التنفس.&nbsp;يزيد احتمالية تعرضك ل نوبة (تشنجات) إذا تناولته مع&nbsp;أقراص&nbsp;ليفون</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضاداتالالتهابات غير الستيرويدية (NSAIDS) - تستخدم لتخفيف الآلام والالتهاب مثل الأسبرينوالايبوبروفين،&nbsp;فينبوفين،&nbsp;كيتوبروفين&nbsp;وإندوميثاسين.&nbsp;يزيد احتمالية تعرضك لنوبة (تشنجات) إذا تناولتها مع أقراص ليفون.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيكلوسبورين - يستخدم بعد زرع الأعضاء.&nbsp;قد تكون أكثر احتمالا للتعرضل الأعراض الجانبية للسيكلوسبورين</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المعروفة بتأثيرها على طريقة دقات قلبك.&nbsp;وهذا يشمل الأدوية المستخدمة لعلاج ضربات القلب&nbsp; الغير طبيعية (مضادات اضطراب النظم&nbsp;مثل&nbsp;كينيدين،&nbsp;هيدروكينيدين،&nbsp;ديسوبيراميد،&nbsp;السوتالول،&nbsp;دوفيتيليد،&nbsp;إيبيوليتيد&nbsp;والأميودارون)،&nbsp;لعلاج الاكتئاب&nbsp;(مضادات&nbsp;الاكتئاب&nbsp;ثلاثية الحلقات&nbsp;مثل&nbsp;اميتريبتالين&nbsp;وإيميبرامين)،&nbsp;لعلاج الاضطرابات النفسية (مضادات الذهان)، ولعلاج العدوى البكتيرية (&nbsp;المضادات الحيوية من مجموعة &quot; الماكرولايد&nbsp;&quot; مثلالاريثروميسين،&nbsp;أزيثروميسين&nbsp;وكلاريثروميسين)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بروبنسيد&nbsp;- يستخدم لعلاج النقرس&nbsp;وسيميتيدين&nbsp;- يستخدم للقرحة والحرقة.&nbsp;يجب توخي الحذر عند تناول أي من هذه الأدوية مع&nbsp;أقراص&nbsp;ليفون&nbsp;.&nbsp;إذا كنت تعاني من مشاكل في الكلى ، فقد يرغب طبيبك في إعطائك جرعة أقل.</p><p dir="RTL"><strong>لا تتناول</strong>&nbsp;<strong>أقراص</strong>&nbsp;<strong>ليفون</strong>&nbsp;<strong>في نفس الوقت مع الأدوية التالية.</strong>&nbsp;<strong>هذا لأنه يمكن أن يؤثر على طريقة</strong>&nbsp;<strong>عمل</strong>&nbsp;<strong>أقراص</strong>&nbsp;<strong>ليفون</strong>&nbsp;<strong>:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;أقراص الحديد (لفقر الدم) ، مكملات الزنك ، المغنيسيوم أو مضادات الحموضة التي تحتوي على الألمنيوم (للحامض أو حرقة الفؤاد) ،&nbsp;ديدانوسين&nbsp;، أو&nbsp;ساكرالفيت&nbsp;(لقرحة المعدة).&nbsp;اﻧظر اﻟﻘﺳم 3 &quot;إذا ﮐﻧت ﺗﺗﻧﺎول ﺑﺎﻟﻔﻌل&nbsp;أقراصالحديد ،&nbsp;أو&nbsp;ﻣﮐﻣﻼت اﻟزﻧك ،&nbsp;أو&nbsp;ﻣﺿﺎدّات&nbsp;اﻟﺣﻣﺎض&nbsp;،&nbsp;أو&nbsp;اﻟدﯾﺎﻧوزﯾن&nbsp;أو&nbsp;اﻟﺳاﮐرالفيت&quot; أدﻧﺎه.</p><p dir="RTL"><strong>اختبارات البول للمهدئات</strong></p><p dir="RTL">قد تظهر اختبارات البول نتائج &quot;إيجابية كاذبة&quot; لمسكنات الألم القوية المسماة &quot;الأفيونات&quot; في الأشخاص الذين يتناولون&nbsp;أقراص&nbsp;ليفون&nbsp;.&nbsp;إذا كان من المقرر أن يقوم الطبيب بإجراء&nbsp;اختبار&nbsp;البول&nbsp;، أخبره أنك تتناول&nbsp;أقراص&nbsp;ليفون&nbsp;أقراص&nbsp;.</p><p dir="RTL"><strong>اختبارات السل</strong></p><p dir="RTL">قد يسبب هذا الدواء نتائج &quot;سلبية كاذبة&quot; لبعض الاختبارات المستخدمة في المختبر للبحث عن&nbsp;البكتيريا المسببة لمرض السل.</p><p dir="RTL"><strong>تناول</strong>&nbsp;<strong>أقراص</strong>&nbsp;<strong>ليفون</strong>&nbsp;<strong>مع الطعام والشراب</strong></p><p dir="RTL">تناوله دون النظر إلى وجبات الطعام.&nbsp;تناوله بالماء واشرب الكثير من الماء.&nbsp;يمكن أن يؤدي تناول هذا الدواء مععصير البرتقال إلى تقليل&nbsp;مستويات البلازما&nbsp;من&nbsp;الكينولونات&nbsp;.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">يجب عدم تناول&nbsp;أقراص&nbsp;ليفون&nbsp;إذا كنت حاملاً أو تخططينل الحمل أو الرضاعة الطبيعية.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">قد تتعرضلأعراض جانبية بعد تناول هذا الدواء، بما في ذلك الشعور بالدوار،والنعاس، والشعور بالدوار أو التغييرات في بصرك.&nbsp;بعض هذه الأعراض الجانبية يمكن أن تؤثر على قدرتك على التركيز وسرعة رد الفعل.&nbsp;إذا حدث ذلك، فلا تقد أو تقومبأي عمل يتطلب درجة عالية من التركيز.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">دائما تناول&nbsp;<strong>أقراص</strong>&nbsp;<strong>ليفون</strong>&nbsp;تمامًا كما أخبرك طبيبك.&nbsp;يجب عليك مراجعة طبيبك أو الصيدلي إذا كنت غير متأكد.</p><p dir="RTL"><strong>تناول هذا الدواء</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;تناول هذا الدواء عن طريق الفم</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ابتلع الأقراص كاملة مع كوب من الماء</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;يمكن تناول الأقراص أثناء الوجبات أو في أي وقت بين الوجبات</p><p dir="RTL"><strong>احمي بشرتك من أشعة الشمس</strong></p><p dir="RTL">ابتعد عن أشعة الشمس المباشرة أثناء تناول هذا الدواء ولمدة يومين بعد التوقف عن تناوله.&nbsp;هذا لأن بشرتك ستصبح أكثر حساسية للشمس وقد تحترق أو تبلى أو تنفجر بشدة إذا لم تتخذ الاحتياطات التالية:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تأكد من استخدام كريم واقي من الشمس ذو معامل عالي</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احرص دائما على ارتداء قبعة وملابس التي تغطي ذراعيك وساقيك</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تجنب أسرة الشمس</p><p dir="RTL"><strong>إذاﮐﻧتﺗﺗﻧﺎولﺑﺎﻟﻔﻌلأقراصالحديد،أوﻣﮐﻣﻼتاﻟزﻧك،أوﻣﺿﺎدّاتاﻟﺣﻣﺎض،أواﻟدﯾﺎﻧوزﯾنأواﻟﺳاﮐرالفيت</strong>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;لا تتناول هذه الأدوية في نفس الوقت مع&nbsp;أقراص&nbsp;ليفون&nbsp;.&nbsp;خذ جرعة من هذه الأدوية على الأقل قبل ساعتين من أو بعد&nbsp;أقراص&nbsp;ليفون&nbsp;.</p><p dir="RTL"><strong>الجرعة</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;سيقرر طبيبك كم عدد&nbsp;أقراص&nbsp;ليفون&nbsp;التي يجب عليك&nbsp;تناولها</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ستعتمد الجرعة على نوع العدوى التي تعاني منها وأينتوجد العدوى في جسمك.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;يعتمد طول فترة علاجك على مدى خطورة الإصابة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;إذا شعرت أن تأثير الدواء ضعيف أو قوي ، لا تغير الجرعة بنفسك ، ولكن اسأل طبيبك.</p><p dir="RTL"><strong>الكبار والمسنين</strong></p><p dir="RTL"><strong>الجيوب البكتيرية الحادة:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 500&nbsp;ملجم، &nbsp;مرة واحدة كل يوم لمدة 10-14.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 750&nbsp;ملجم، &nbsp;مرة واحدة كل يوم لمدة 5 أيام.</p><p dir="RTL"><strong>الالتهاب الرئوي:</strong></p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;الالتهاب الرئوي المكتسب في</strong>&nbsp;<strong>المستشفي</strong>&nbsp;<strong>:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;750 ملجم، مرة واحدة كل يوم&nbsp;لمدة 7-14 يوم&nbsp;<strong>.</strong></p><p dir="RTL"><strong>الالتهاب الرئوي المكتسب منالمجتمع:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;500 ملجم، مرة واحدة كل يوم لمدة 10-14</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;750&nbsp;ملجم، &nbsp;مرة واحدة كل يوم لمدة 5 أيام.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong>التفاقم البكتيري الحاد لالتهاب الشعب الهوائية المزمن:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;500&nbsp;ملجم، &nbsp;مرة واحدة كل يوم لمدة 7 أيام.</p><p dir="RTL"><strong>التهاب المسالك البولية المعقدة أو التهاب</strong>&nbsp;<strong>الحويضة والكلية</strong>&nbsp;<strong>الحاد</strong>&nbsp;<strong>.</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;750 ملجم، كل يوم&nbsp;لمدة 5 أيام.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;250 ملجم، كل يوم&nbsp;لمدة 10 أيام.</p><p dir="RTL"><strong>عدوى المسالك البولية الغير معقدة:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;250 ملجم، كل يوم&nbsp;لمدة 3 أيام&nbsp;<strong>.</strong></p><p dir="RTL"><strong>عدوى البروستاتا</strong>&nbsp;<strong>البكتيري المزمن</strong>&nbsp;<strong>.</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;500 ملجم، مرة واحدة كل يوم لمدة 28 يومًا.</p><p dir="RTL"><strong>العدوى المعقدة للبشرة والجلد (</strong><strong>SSSI</strong><strong>):</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;750 ملجم، مرة واحدة كل يوم&nbsp;لمدة 7-14 يوم.</p><p dir="RTL"><strong>العدوى الغير معقدة (</strong><strong>SSSI</strong><strong>):</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;500 ملجم، مرة واحدة كل يوم لمدة 7-10 أيام.</p><p dir="RTL"><strong>البالغين والمسنين الذين يعانون من مشاكل في الكلى</strong></p><p dir="RTL">قد يحتاج طبيبك أن يعطيك جرعة أقل.</p><p dir="RTL"><strong>الأطفال والمراهقون</strong></p><p dir="RTL">لا يجب إعطاء هذا الدواء للأطفال أو المراهقين.</p><p dir="RTL"><strong>الجرعة الزائدة</strong></p><p dir="RTL">إذا تناولت عن طريق الخطأ عددًا أكبر من الأقراص، فأخبر طبيبًك أو أيمختص طبيآخر فورًا.&nbsp;خذ معك عبوة الدواء&nbsp;للطبيب حتى يعرف ماذا تناولت.&nbsp;قد تحدث التأثيرات التالية: نوبات تشنجية (نوبات) ، الشعور بالارتباك ، بالدوار ، قلة الوعي، وجود مشاكل في القلب والرعاش - تؤدي إلى دقات قلب غير متناسقة بالإضافة إلى الشعور بالغثيان أو حرق المعدة.</p><p dir="RTL"><strong>إذا نسيت أن تتناول جرعة من</strong>&nbsp;<strong>أقراص</strong>&nbsp;<strong>ليفون</strong></p><p dir="RTL">إذا نسيت أن تتناولجرعة، خذها حالما تتذكر ما لم يكن الوقت قد حان لجرعتك التالية.</p><p dir="RTL">لا تضاعف الجرعة التالية لتعويض الجرعة المنسية.</p><p dir="RTL"><strong>إذا توقفت عن تناول</strong>&nbsp;<strong>أقراص</strong>&nbsp;<strong>ليفون</strong></p><p dir="RTL">لا تتوقف عن تناول&nbsp;أقراص&nbsp;ليفون فقط لأنك تشعر بتحسن.&nbsp;من المهم&nbsp;أن تكمل&nbsp;مدة الأقراص&nbsp;التي وصفها لك الطبيب.&nbsp;إذا&nbsp;توقفت عن تناول الأقراص&nbsp;مبكرا، قد&nbsp;تعود الإصابة،أو تزداد&nbsp;حالتك&nbsp;سوءا&nbsp;أو قد تصبح البكتيريا مقاومة&nbsp;للدواء.</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء ، اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية ، يمكن أن يسبب هذا الدواء أعراضا جانبية ، على الرغم من عدم تعرض الجميع لها.&nbsp;وعادة ما تكون هذه التأثيرات خفيفة أو معتدلة وتختفي في كثير من الأحيان بعد وقت قصير.</p><p dir="RTL"><strong>توقف عن تناول</strong>&nbsp;<strong>أقراص</strong>&nbsp;<strong>ليفون</strong>&nbsp;<strong>وراجع الطبيب أو اذهب إلى المستشفى على الفور إذا</strong>&nbsp;<strong>لاحظت&nbsp;الأعراضالجانبية التالية:</strong></p><p dir="RTL"><strong>نادر</strong>&nbsp;(قد يؤثر على ما يصل إلى 1 في&nbsp;1000 شخص)</p><p dir="RTL">&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رد فعل تحسسي.&nbsp;قد تشتمل الأعراض على: طفح جلدي، مشاكل في البلع أو التنفس، تورم في الشفتين أو الوجه أو الحنجرة أو اللسان، انخفاض سريع في ضغط الدم (مع أعراض مثل التنفس الضحل والدوار وضعف النبض)</p><p dir="RTL">&nbsp;</p><p dir="RTL">توقف عن تناول&nbsp;أقراص&nbsp;ليفون&nbsp;وراجع الطبيب فورا إذا لاحظت&nbsp;<strong>أي من</strong>&nbsp;<strong>الأعراض</strong>&nbsp;الجانبية&nbsp;<strong>التالية</strong>&nbsp;- قد تحتاج إلى علاج طبي عاجل:</p><p dir="RTL"><strong>نادر</strong>&nbsp;(قد يؤثر على 1 من كل 1000 شخص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;الألم والالتهاب في الأوتار أو الأربطة ، مما قد يؤدي إلى تمزق.&nbsp;في أغلب الأحيان يتأثر وتر العرقوب</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;نوبات (التشنجات)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير معروف</strong>&nbsp;(لا يمكن تقدير التردد من البيانات المتاحة)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي حاد قد يشمل تقرحات أو تقشير الجلد حول الشفاه والعيون والفم والأنف والأعضاء التناسلية أو طفح جلدي مع بقع مستديرة شبيهة بالحصبة والحمى وآلام المفاصل.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيير في رأيك وأفكارك مع خطر حدوث أفكار أو أعمال انتحارية.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية والغثيان والقيء ويصبحالجلد والعينين صفراء&nbsp;اللون&nbsp;أو البول الملون أو الحمى أو الحكة أو تعريض المعدة (البطن).&nbsp;قد تكون هذه علامات على مشاكل في الكبد والتي قد تشمل فشلًا فادحًا في الكبد.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال مائي قد يحتوي على دم ، مع احتمال حدوث تشنجات في المعدة ودرجة حرارة عالية.&nbsp;قد تكون هذه علامات على وجود مشكلة شديدة في الأمعاء.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إيقاع غير طبيعي سريع في القلب، إيقاع غير منتظم في القلب يهدد الحياة، بما في ذلك السكتة القلبية، وتغيير إيقاع القلب (يُطلق عليه &quot;إطالة فترة QT&quot;، ويظهر في تخطيط القلب الكهربائي، النشاط الكهربائي للقلب).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حرقان ، وخز ، ألم أو خدر.&nbsp;قد تكون هذه علامات على شيء يسمى &quot;الاعتلال العصبي&quot;.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا تعرضت ل ضعف البصر أو إذا كان لديك أي اضطرابات أخرى في العين أثناء تناول&nbsp;الليفوفلوكساسين&nbsp;، استشر طبيب العيون على الفور.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أخبر طبيبك إذا كان أي من الأعراض الجانبية التالية</strong>&nbsp;ازدادت حدتها&nbsp;<strong>أو</strong>&nbsp;دامت أكثر من بضعة أيام:</p><p dir="RTL"><strong>شائع</strong>&nbsp;(قد يؤثر على شخص واحد من كل 10 أشخاص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل النوم</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع، والشعور بالدوار</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالغثيان (الغثيان والقيء) والإسهال</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مستوى بعض إنزيمات الكبد في دمك</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>غير شائع</strong>&nbsp;(قد يؤثر على شخص واحد من بين كل 100 شخص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغيرات في عدد البكتريا أو الفطريات الأخرى، العدوى بالفطر المسمى كانديدا ، والتي قد تحتاج إلى علاج</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغيرات في عدد كريات الدم البيضاء التي تظهر في نتائج بعض اختبارات الدم (&nbsp;نقص الكريات البيضاء&nbsp;،&nbsp;فرط الحمضات&nbsp;)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالتوتر (القلق)، الشعور بالارتباك، الشعور بالتوتر، الشعور بالنعاس،الارتعاش، الشعور بالدوار</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق في التنفس&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغيرات في طريقة تذوق الأشياء، وفقدان الشهية، واضطراب المعدة أو عسر الهضم ، أو الألم في منطقة المعدة، أو الشعور بالانتفاخ (انتفاخ البطن) أو الإمساك</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحكة والطفح الجلدي ، والحكة الشديدة والارتكاريا (&nbsp;الشرى&nbsp;) ، والتعرق أكثر من اللازم (&nbsp;فرط التعرق&nbsp;)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام المفاصل أو العضلات</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تظهر اختبارات الدم نتائج غير عادية بسبب مشاكل الكبد (زيادة&nbsp;البيليروبين) أوالكلى(&nbsp;زيادة&nbsp;الكرياتينين&nbsp;)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف عام</p><p dir="RTL"><strong>نادر</strong>&nbsp;(قد يؤثر على 1 من كل 1000 شخص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;الكدمات والنزيف بسهولة بسبب انخفاض عدد الصفائح الدموية (نقص الصفيحات الدموية)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;انخفاض عدد خلايا الدم البيضاء (&nbsp;قلة العدلات&nbsp;)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;استجابة مناعية مبالغ فيها (فرط الحساسية)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;خفض مستويات السكر في الدم (&nbsp;نقص سكر الدم&nbsp;).&nbsp;هذا مهم للأشخاص الذين يعانون من مرض السكري.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;تغييرات في صحتك العقلية&nbsp;مثل&nbsp;رؤية أو سماع أشياء غير موجودة (الهلوسة وجنون العظمة)، وتغير في الرأي والأفكار (ردود فعل نفسية) مع خطر وجود أفكار أو أعمال انتحارية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;الشعور بالاكتئاب ، ومشاكل عقلية ، والشعور بعدم الراحة (الهياج) ، والأحلام غير الطبيعية أو الكوابيس</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;شعور بوخز في يديك وقدميك (المذل&nbsp;)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;مشاكل في السمع (الطنين) أو البصر (عدم وضوح الرؤية)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ضربات سريعة غير عادية لقلبك (عدم انتظام دقات القلب) أو انخفاض ضغط الدم (انخفاض ضغط الدم)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ضعف العضلات.&nbsp;هذا أمر مهم في الأشخاص الذين يعانون من الوهن العضلي الوبيل (وهو&nbsp;مرض&nbsp;نادر&nbsp;في الجهاز العصبي).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;التغيرات في الطريقة التي تعمل&nbsp;بها&nbsp;الكلية والفشل الكلوي العرضي الذي قد&nbsp;يكون&nbsp;ناتجًا عن رد فعل تحسسي للكلى يسمى التهاب الكلية الخلالي.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;حمى</p><p dir="RTL"><strong>غير معروف</strong>&nbsp;(لا يمكن تقدير التردد من البيانات المتاحة):</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;انخفاض في خلايا الدم الحمراء (فقر الدم): هذا يمكن أن يجعل البشرة شاحبة أو صفراء بسبب تلف خلايا الدم الحمراء.&nbsp;انخفاض في عدد جميع أنواع خلايا الدم (&nbsp;قلة الكريات الشاملة&nbsp;)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;الحمى والتهاب الحلق والشعور العام بعدم الارتياح الذي لا يختفي.&nbsp;قد يكون هذا بسبب انخفاض في عدد خلايا الدم البيضاء (&nbsp;ندرة المحببات&nbsp;).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;زيادة مستويات السكر في الدم (&nbsp;فرط سكر الدم&nbsp;) أو خفض مستويات السكر في الدم مما يؤدي إلى غيبوبة (&nbsp;غيبوبة&nbsp;نقص سكر الدم&nbsp;).&nbsp;هذا مهم للأشخاص الذين يعانون من مرض السكري.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;تغييرات في رائحة أشياء، وفقدان الشم أو التذوق&nbsp;(خلل أو فقد حاسة&nbsp;الشم، &nbsp;فقد حاسة&nbsp;التذوق)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;مشاكل في الحركة والمشي (&nbsp;خلل الحركة&nbsp;،&nbsp;اضطرابات&nbsp;خارج السبيل الهرمي&nbsp;)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;فقدان مؤقت للوعي أو وضع الجسم (الإغماء)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;فقدان مؤقت في الرؤية&nbsp;، التهاب في العين</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;انخفاض أو فقدان السمع</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;صعوبة في التنفس أو الصفير (&nbsp;تشنج قصبي&nbsp;)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ردود فعل الرئة التحسسي</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ألم في الجزء العلوي من البطن والظهر، الشعور أو المرض الذي قد يكون سببه التهاب البنكرياس</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;زيادة حساسية بشرتك لأشعة الشمس والأشعة فوق البنفسجية (حساسية للضوء)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;التهاب الأوعية التي تحمل الدم في جميع أنحاء جسمك بسبب رد فعل تحسسي (&nbsp;التهاب الأوعية الدموية&nbsp;)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;التهاب الأنسجة داخل الفم (&nbsp;التهاب الفم&nbsp;)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;تمزق العضلات وتدمير العضلات (&nbsp;انحلال الربيدات&nbsp;)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;احمرار وتورم المفاصل (التهاب المفاصل)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ألم، بما في ذلك ألم في الظهر والصدر والأطراف</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;نوبات&nbsp;البورفيريا&nbsp;عند الأشخاص الذين لديهم بالفعل&nbsp;البورفيريا&nbsp;(وهو أحد الأمراض الأيضية النادرة جدا)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;صداع مستمر مع أو بدون تشوش الرؤية (ارتفاع ضغط الدم الحميد داخل الجمجمة)</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">إذا تعرضتلأي أعراضجانبية، تحدث مع طبيبك أو الصيدلي أو الممرضة.&nbsp;يتضمن ذلك أي أعراض جانبية محتملة غير مدرجة في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حافظ على هذا الدواء بعيدا عن متناول ونظر الأطفال.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يحفظ في درجة حرارة أعلى من 30 درجة مئوية</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المطبوع على الكرتون والشريط بعد&nbsp;كلمة EXP.&nbsp;يشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية.&nbsp;اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدمها.&nbsp;هذه التدابير سوف تساعد في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة ليفوفلوكساسين. يحتوي كل قرص مغلف بطبقة رقيقة من <strong>ليفون</strong><strong> </strong>250 ملجم أقراص مغلفة بطبقة رقيقة على250 ملجم من مادة ليفوفلوكساسين، يحتوي كل قرص مغلف بطبقة رقيقة من ليفون 500 ملجم أقراص مغلفة بطبقة رقيقة على 500 ملجم من مادة ليفوفلوكساسين، يحتوي كل قرص مغلف بطبقة رقيقة من ليفون 750 ملجم أقراص مغلفة بطبقة رقيقة على 750 ملجم من مادة ليفوفلوكساسين.</p><p dir="RTL">المواد الغير فعالة بالقرص: هيدروكسي بروبايل ميثيل سيلليلوز، كروسبوفيدون، مايكروكريستالين سيلليلوز مضاف إليها السيليكا، ستيارات المغنيسيوم.</p><p dir="RTL">الطبقة المغلفة: بولي سوربات 80 ، ثاني أكسيد التيتانيوم، تالك نقي، بولي إيثيلين جليكول، هيدروكسي بروبايل ميثيل</p><p dir="RTL">سيلليلوز، أكسيد الحديد الأصفر.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right"><strong>أقراص</strong><strong> </strong><strong>ليفون</strong><strong> </strong>250 <strong>ملجم</strong><strong> </strong>هي أقراص مغلفة بطبقة رقيقة للتناول عن طريق الفم وهي أقراص مستطيلة لونها أصفر فاتح.</p><p dir="RTL" style="text-align:right"><strong>أقراص</strong><strong> </strong><strong>ليفون</strong><strong> </strong>500 <strong>ملجم</strong><strong> </strong>هي أقراص صفراء، مستطيلة، والأقراص مغلفة بطبقة رقيقة محدبة الوجهين محفورة ب</p><p dir="RTL" style="text-align:right">&quot;T211&quot; على جانب واحد وخالية من العلامات على الجانب الآخر.</p><p dir="RTL" style="text-align:right"><strong>أقراص</strong><strong> </strong><strong>ليفون</strong><strong> </strong>750 <strong>ملجم</strong><strong> </strong>هي أقراص صفراء، مستطيلة، والأقراص مغلفة بطبقة رقيقة محدبة الوجهين محفورة ب</p><p dir="RTL" style="text-align:right">&quot;T212&quot; على جانب واحد وخالية من العلامات على الجانب الآخر.</p><p dir="RTL" style="text-align:right">يتوفر <strong>ليفون</strong><strong> </strong>250 ، 500 ، 750 ملجم في عبوات تحتوي على 5 أقراص.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">الدمام فارما</p><p dir="RTL">العنوان: المدينة الصناعية الأولى , وحدة رقم 1 , صندوق بريد: 7137 , الدمام 32234 &ndash; 4384</p><p dir="RTL">تليفون: 966138216444+</p><p dir="RTL">فاكس: 966138216422+</p><p dir="RTL">البريد الإلكتروني: regulatory-affairs@dammampharma.sa</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
             نوفمبر2018. 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Levon 250 mg film-coated tablets
Levon 500 mg film-coated tablets
Levon 750 mg film-coated tablets

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film-coated tablet contains 250,500 & 750 mg of levofloxacin 
For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablets
Levon 250mg tablets are film-coated tablets for oral use. The tablets are oblong with light yellow colour.

Levon 500mg tablets are yellow, oblong, biconvex film coated tablets engraved with a “T211” on one side and a plain surface on the other side.

Levon 750mg tablets are yellow, oblong, biconvex film coated tablets engraved with a “T212” on one side and a plain surface on the other side.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Levon tablets are indicated in adults for the treatment of the following infections (see sections 4.4 and 5.1):</p><p>&bull; Acute bacterial sinusitis</p><p>&bull; Acute exacerbations of chronic bronchitis</p><p>&bull; Community-acquired pneumonia</p><p>&bull; Complicated skin and soft tissue infections</p><p>For the above-mentioned infections Levon tablets should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections.</p><p>&bull; Pyelonephritis and complicated urinary tract infections (see section 4.4)</p><p>&bull; Chronic bacterial prostatitis</p><p>&bull; Uncomplicated cystitis (see section 4.4)</p><p>&bull; Inhalation Anthrax: postexposure prophylaxis and curative treatment (see section 4.4)</p><p>Levon tablets may also be used to complete a course of therapy in patients who have shown improvement during initial treatment with intravenous levofloxacin.</p><p>Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Levon tablets are administered once or twice daily. The dosage depends on the type and severity of the infection and the susceptibility of the presumed causative pathogen.</p><p>Levon tablets may also be used to complete a course of therapy in patients who have shown improvement during initial treatment with intravenous levofloxacin; given the bioequivalence of the parenteral and oral forms, the same dosage can be used.</p><p><u>Posology</u></p><p>The following dose recommendations can be given for Levofloxacin:</p><p><strong><em>Dosage in patients with normal renal function</em></strong><strong>&nbsp;</strong>(creatinine clearance &gt; 50 ml/min)</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p><strong>Indication</strong></p></td><td style="vertical-align:top"><p><strong>Daily dose regimen</strong></p><p><strong><em>(according to severity)</em></strong></p></td><td style="vertical-align:top"><p><strong>Duration of treatment</strong></p><p><strong><em>(according to severity)</em></strong></p></td></tr><tr><td style="vertical-align:top"><p>Acute bacterial sinusitis</p></td><td style="vertical-align:top"><p>500 mg once daily</p></td><td style="vertical-align:top"><p>10 - 14 days</p></td></tr><tr><td style="vertical-align:top"><p>Acute bacterial exacerbations of chronic bronchitis</p></td><td style="vertical-align:top"><p>500 mg once daily</p></td><td style="vertical-align:top"><p>7 - 10 days</p></td></tr><tr><td style="vertical-align:top"><p>Community-acquired pneumonia</p></td><td style="vertical-align:top"><p>500 mg once or twice daily</p></td><td style="vertical-align:top"><p>7 - 14 days</p></td></tr><tr><td style="vertical-align:top"><p>Pyelonephritis</p></td><td style="vertical-align:top"><p>500 mg once daily</p></td><td style="vertical-align:top"><p>7 &ndash; 10 days</p></td></tr><tr><td style="vertical-align:top"><p>Complicated urinary tract infections</p></td><td style="vertical-align:top"><p>500 mg once daily</p></td><td style="vertical-align:top"><p>7 - 14 days</p></td></tr><tr><td style="vertical-align:top"><p>Uncomplicated cystitis</p></td><td style="vertical-align:top"><p>250 mg once daily</p></td><td style="vertical-align:top"><p>3 days</p></td></tr><tr><td style="vertical-align:top"><p>Chronic bacterial prostatitis.</p></td><td style="vertical-align:top"><p>500 mg once daily</p></td><td style="vertical-align:top"><p>28 days</p></td></tr><tr><td style="vertical-align:top"><p>Complicated skin and soft tissue infections</p></td><td style="vertical-align:top"><p>500 mg once or twice daily</p></td><td style="vertical-align:top"><p>7 - 14 days</p></td></tr><tr><td style="vertical-align:top"><p>Inhalation Anthrax</p></td><td style="vertical-align:top"><p>500 mg once daily</p></td><td style="vertical-align:top"><p>8 weeks</p></td></tr></tbody></table><p><em><u>Special populations</u></em></p><p><strong><em>Renal impairment&nbsp;</em></strong>(creatinine clearance &le;50 ml/min)</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top">&nbsp;</td><td colspan="3" style="vertical-align:top"><p><strong>Dose regimen</strong></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p><strong>250 mg/24 h</strong></p></td><td style="vertical-align:top"><p><strong>500 mg/24 h</strong></p></td><td style="vertical-align:top"><p><strong>500 mg/12 h</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Creatinine clearance</strong></p></td><td style="vertical-align:top"><p><em>first dose:</em>&nbsp;250 mg</p></td><td style="vertical-align:top"><p><em>first dose:</em>&nbsp;500 mg</p></td><td style="vertical-align:top"><p><em>first dose:</em>&nbsp;500 mg</p></td></tr><tr><td style="vertical-align:top"><p>50-20 ml/min</p></td><td style="vertical-align:top"><p><em>then:</em>&nbsp;125 mg/24 h</p></td><td style="vertical-align:top"><p><em>then</em>&nbsp;: 250 mg/24 h</p></td><td style="vertical-align:top"><p><em>then</em>&nbsp;: 250 mg/12 h</p></td></tr><tr><td style="vertical-align:top"><p>19-10 ml/min</p></td><td style="vertical-align:top"><p><em>then:</em>&nbsp;125 mg/48 h</p></td><td style="vertical-align:top"><p><em>then</em>&nbsp;: 125 mg/ 24 h</p></td><td style="vertical-align:top"><p><em>then</em>&nbsp;: 125 mg/12 h</p></td></tr><tr><td style="vertical-align:top"><p>&lt; 10 ml/min</p><p>(including haemodialysis and CAPD)&nbsp;<sup>1</sup></p></td><td style="vertical-align:top"><p><em>then:</em>&nbsp;125 mg/48 h</p></td><td style="vertical-align:top"><p><em>then:</em>&nbsp;125 mg/24 h</p></td><td style="vertical-align:top"><p><em>then:</em>&nbsp;125 mg/24 h</p></td></tr></tbody></table><p><sup>1</sup>&nbsp;No additional doses are required after haemodialysis or continuous ambulatory peritoneal dialysis (CAPD).</p><p><strong><em>Hepatic impairment</em></strong></p><p>No adjustment of dosage is required since levofloxacin is not metabolised to any relevant extent by the liver and is mainly excreted by the kidneys.</p><p><strong><em>Elderly</em></strong></p><p>No adjustment of dose is required in the elderly, other than that imposed by consideration of renal function (see section 4.4 &ldquo;Tendintis and tendon rupture&rdquo; and &ldquo;QT interval prolongation&rdquo;).</p><p><strong><em>Paediatric population</em></strong></p><p>Levofloxacin is contraindicated in children and growing adolescents (see section 4.3).</p><p><strong><em>Method of administration</em></strong></p><p>For oral use.</p><p>Levon tablets should be swallowed without crushing and with sufficient amount of liquid. They may be divided at the score line to adapt the dose. The tablets may be taken during meals or between meals. Levon tablets should be taken at least two hours before or after iron salts, zinc salts, magnesium- or aluminium-containing antacids, or didanosine (<em>only didanosine formulations with aluminium or magnesium containing buffering agents</em>), and sucralfate administration, since reduction of absorption can occur (see section 4.5).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Levon tablets must not be used:
• in patients hypersensitive to the active substance or other quinolones or to any of the excipients listed in section 6.1,
• in patients with epilepsy,
• in patients with history of tendon disorders related to fluoroquinolone administration,
• in children or growing adolescents,
• during pregnancy,
• in breast-feeding women.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Epidemiologic studies report an increased risk of aortic aneurysm and dissection after intake of fluoroquinolones, particularly in the older population.</p><p>&nbsp;</p><p>Therefore, fluoroquinolones should only be used after careful benefit-risk assessment and after consideration of other therapeutic options in patients with positive family history of aneurysm disease, or in patients diagnosed with pre-existing aortic aneurysm and/or aortic dissection, or in presence of other risk factors or conditions predisposing for aortic aneurysm and dissection (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, Takayasu arteritis, Behcet`s disease, hypertension, known atherosclerosis).</p><p>&nbsp;</p><p>In case of sudden abdominal, chest or back pain, patients should be advised to immediately consult a physician in an emergency department.</p><p><strong>&nbsp;</strong></p><p>Methicillin resistant<em>&nbsp;S. aureus</em>&nbsp;are very likely to possess co-resistance to fluoroquinolones, including levofloxacin. Therefore levofloxacin is not recommended for the treatment of known or suspected MRSA infections unless laboratory results have confirmed susceptibility of the organism to levofloxacin (and commonly recommended antibacterial agents for the treatment of MRSA-infections are considered inappropriate).</p><p>Levofloxacin may be used in the treatment of Acute Bacterial Sinusitis and Acute Exacerbation of Chronic Bronchitis when these infections have been adequately diagnosed.</p><p>Resistance to fluoroquinolones of&nbsp;<em>E. coli</em>&nbsp;&ndash; the most common pathogen involved in urinary tract infections &ndash; varies across the European Union. Prescribers are advised to take into account the local prevalence of resistance in&nbsp;<em>E. coli</em>&nbsp;to fluoroquinolones.</p><p>Inhalation Anthrax: Use in humans is based on&nbsp;<em>in vitro Bacillus anthracis</em>&nbsp;susceptibility data and on animal experimental data together with limited human data. Treating physicians should refer to national and/or international consensus documents regarding the treatment of anthrax.</p><p><strong><em>Tendinitis and tendon rupture</em></strong></p><p>Tendinitis may rarely occur. It most frequently involves the Achilles tendon and may lead to tendon rupture. Tendinitis and tendon rupture, sometimes bilateral, may occur within 48 hours of starting treatment with levofloxacin and have been reported up to several months after discontinuation of treatment. The risk of tendinitis and tendon rupture is increased in patients aged over 60 years, in patients receiving daily doses of 1000 mg and in patients using corticosteroids. The daily dose should be adjusted in elderly patients based on creatinine clearance (see section 4.2). Close monitoring of these patients is therefore necessary if they are prescribed levofloxacin. All patients should consult their physician if they experience symptoms of tendinitis. If tendinitis is suspected, treatment with levofloxacin must be halted immediately, and appropriate treatment (e.g. immobilisation) must be initiated for the affected tendon (see sections 4.3 and 4.8).</p><p><strong><em>Clostridium difficile-associated disease</em></strong></p><p>Diarrhoea, particularly if severe, persistent and/or bloody, during or after treatment with levofloxacin (including several weeks after treatment), may be symptomatic of&nbsp;<em>Clostridium difficile</em>-associated disease (CDAD). CDAD may range in severity from mild to life threatening, the most severe form of which is pseudomembranous colitis (see section 4.8). It is therefore important to consider this diagnosis in patients who develop serious diarrhoea during or after treatment with levofloxacin. If CDAD is suspected or confirmed, levofloxacin should be stopped immediately and appropriate treatment initiated without delay. Anti-peristaltic medicinal products are contraindicated in this clinical situation..</p><p><strong><em>Patients predisposed to seizures</em></strong></p><p>Quinolones may lower the seizure threshold and may trigger seizures. Levofloxacin is contraindicated in patients with a history of epilepsy (see section 4.3) and, as with other quinolones, should be used with extreme caution in patients predisposed to seizures or concomitant treatment with active substances that lower the cerebral seizure threshold, such as theophylline (see section 4.5). In case of convulsive seizures (see section 4.8), treatment with levofloxacin should be discontinued.</p><p><strong><em>Patients with G-6- phosphate dehydrogenase deficiency</em></strong></p><p>Patients with latent or actual defects in glucose-6-phosphate dehydrogenase activity may be prone to haemolytic reactions when treated with quinolone antibacterial agents. Therefore, if levofloxacin has to be used in these patients, potential occurrence of haemolysis should be monitored.</p><p><strong><em>Patients with renal impairment</em></strong></p><p>Since levofloxacin is excreted mainly by the kidneys, the dose of Levofloxacin should be adjusted in patients with renal impairment (see section 4.2).</p><p><strong><em>Hypersensitivity reactions</em></strong></p><p>Levofloxacin can cause serious, potentially fatal hypersensitivity reactions (e.g. angioedema up to anaphylactic shock), occasionally following the initial dose (see section 4.8). Patients should discontinue treatment immediately and contact their physician or an emergency physician, who will initiate appropriate emergency measures.</p><p><strong><em>Severe bullous reactions</em></strong></p><p>Cases of severe bullous skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis have been reported with levofloxacin (see section 4.8). Patients should be advised to contact their doctor immediately prior to continuing treatment if skin and/or mucosal reactions occur.</p><p><strong><em>Dysglycaemia</em></strong></p><p>As with all quinolones, disturbances in blood glucose, including both hypoglycaemia and hyperglycaemia have been reported, usually in diabetic patients receiving concomitant treatment with an oral hypoglycaemic agent (e.g., glibenclamide) or with insulin. Cases of hypoglycaemic coma have been reported. In diabetic patients, careful monitoring of blood glucose is recommended see section 4.8).</p><p><strong><em>Prevention of photosensitisation</em></strong></p><p>Photosensitisation has been reported with levofloxacin (see section 4.8). It is recommended that patients should not expose themselves unnecessarily to strong sunlight or to artificial UV rays (e.g. sunray lamp, solarium), during treatment and for 48 hours following treatment discontinuation in order to prevent photosensitisation.</p><p><strong><em>Patients treated with Vitamin K antagonists</em></strong></p><p>Due to possible increase in coagulation tests (PT/INR) and/or bleeding in patients treated with levofloxacin in combination with a vitamin K antagonist (e.g. warfarin), coagulation tests should be monitored when these drugs are given concomitantly (see section 4.5).</p><p><strong><em>Psychotic reactions</em></strong></p><p>Psychotic reactions have been reported in patients receiving quinolones, including levofloxacin. In very rare cases these have progressed to suicidal thoughts and self-endangering behaviour- sometimes after only a single dose of levofloxacin (see section 4.8). In the event that the patient develops these reactions, levofloxacin should be discontinued and appropriate measures instituted. Caution is recommended if levofloxacin is to be used in psychotic patients or in patients with history of psychiatric disease.</p><p><strong><em>QT interval prolongation</em></strong></p><p>Caution should be taken when using fluoroquinolones, including levofloxacin, in patients with known risk factors for prolongation of the QT interval such as, for example:</p><p>- congenital long QT syndrome</p><p>- concomitant use of drugs that are known to prolong the QT interval (e.g. Class IA and III anti-arrhythmics, tricyclic antidepressants, macrolides, antipsychotics)</p><p>- uncorrected electrolyte imbalance (e.g. hypokalaemia, hypomagnesaemia)</p><p>- cardiac disease (e.g. heart failure, myocardial infarction, bradycardia)</p><p>Elderly patients and women may be more sensitive to QTc-prolonging medications. Therefore, caution should be taken when using fluoroquinolones, including levofloxacin, in these populations.</p><p>(see sections 4.2&nbsp;<em>Elderly</em>, 4.5, 4.8, and 4.9).</p><p><strong><em>Peripheral neuropathy</em></strong></p><p>Peripheral sensory neuropathy and peripheral sensory motor neuropathy have been reported in patients receiving fluoroquinolones, including levofloxacin, which can be rapid in its onset (see section 4.8). Levofloxacin should be discontinued if the patient experiences symptoms of neuropathy in order to prevent the development of an irreversible condition.</p><p><strong><em>Hepatobiliary disorders</em></strong></p><p>Cases of hepatic necrosis up to fatal hepatic failure have been reported with levofloxacin, primarily in patients with severe underlying diseases, e.g. sepsis (see section 4.8). Patients should be advised to stop treatment and contact their doctor if signs and symptoms of hepatic disease develop such as anorexia, jaundice, dark urine, pruritus or tender abdomen.</p><p><strong><em>Exacerbation of myasthenia gravis</em></strong></p><p>Fluoroquinolones, including levofloxacin, have neuromuscular blocking activity and may exacerbate muscle weakness in patients with myasthenia gravis. Postmarketing serious adverse reactions, including deaths and the requirement for respiratory support, have been associated with fluoroquinolone use in patients with myasthenia gravis. Levofloxacin is not recommended in patients with a known history of myasthenia gravis.</p><p><strong><em>Vision disorders</em></strong></p><p>If vision becomes impaired or any effects on the eyes are experienced, an eye specialist should be consulted immediately (see sections 4.7 and 4.8).</p><p><strong><em>Superinfection</em></strong></p><p>The use of levofloxacin, especially if prolonged, may result in overgrowth of non-susceptible organisms. If superinfection occurs during therapy, appropriate measures should be taken.</p><p><strong><em>Interference with laboratory tests</em></strong></p><p>In patients treated with levofloxacin, determination of opiates in urine may give false-positive results. It may be necessary to confirm positive opiate screens by more specific method.</p><p>Levofloxacin may inhibit the growth of&nbsp;<em>Mycobacterium tuberculosis</em>&nbsp;and, therefore, may give false-negative results in the bacteriological diagnosis of tuberculosis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Effect of other medicinal products on levofloxacin</strong></p><p><strong><em>Iron salts, zinc salts, magnesium- or aluminium-containing antacids, didanosine</em></strong></p><p>Levofloxacin absorption is significantly reduced when iron salts, or magnesium- or aluminium-containing antacids, or didanosine (<em>only didanosine formulations with aluminium or magnesium containing buffering agents</em>) are administered concomitantly with Levon tablets. Concurrent administration of fluoroquinolones with multi-vitamins containing zinc appears to reduce their oral absorption. It is recommended that preparations containing divalent or trivalent cations such as iron salts, zinc salts or magnesium- or aluminium-containing antacids, or didanosine (<em>only didanosine formulations with aluminium or magnesium containing buffering agents</em>) should not be taken 2 hours before or after levofloxacin administration (see section 4.2). Calcium salts have a minimal effect on the oral absorption of levofloxacin.</p><p><strong><em>Sucralfate</em></strong></p><p>The bioavailability of Levon tablets is significantly reduced when administered together with sucralfate. If the patient is to receive both sucralfate and Levofloxacin, it is best to administer sucralfate 2 hours after the levofloxacin tablet administration (see section 4.2).</p><p><strong><em>Theophylline, fenbufen or similar non-steroidal anti-inflammatory drugs</em></strong></p><p>No pharmacokinetic interactions of levofloxacin were found with theophylline in a clinical study. However a pronounced lowering of the cerebral seizure threshold may occur when quinolones are given concurrently with theophylline, non-steroidal anti-inflammatory drugs, or other agents which lower the seizure threshold.</p><p>Levofloxacin concentrations were about 13% higher in the presence of fenbufen than when administered alone.</p><p><strong><em>Probenecid and cimetidine</em></strong></p><p>Probenecid and cimetidine had a statistically significant effect on the elimination of levofloxacin. The renal clearance of levofloxacin was reduced by cimetidine (24%) and probenecid (34%). This is because both drugs are capable of blocking the renal tubular secretion of levofloxacin. However, at the tested doses in the study, the statistically significant kinetic differences are unlikely to be of clinical relevance.</p><p>Caution should be exercised when levofloxacin is co-administered with drugs that affect the tubular renal secretion such as probenecid and cimetidine, especially in renally impaired patients.</p><p><strong><em>Other relevant information</em></strong></p><p>Clinical pharmacology studies have shown that the pharmacokinetics of levofloxacin were not affected to any clinically relevant extent when levofloxacin was administered together with the following drugs: calcium carbonate, digoxin, glibenclamide, ranitidine.</p><p><strong>Effect of Levofloxacin on other medicinal products</strong></p><p><strong><em>Ciclosporin</em></strong></p><p>The half-life of ciclosporin was increased by 33% when co-administered with levofloxacin.</p><p><strong><em>Vitamin K antagonists</em></strong></p><p>Increased coagulation tests (PT/INR) and/or bleeding, which may be severe, have been reported in patients treated with levofloxacin in combination with a vitamin K antagonist (e.g. warfarin). Coagulation tests, therefore, should be monitored in patients treated with vitamin K antagonists (see section 4.4).</p><p><strong><em>Drugs known to prolong QT interval</em></strong></p><p>Levofloxacin, like other fluoroquinolones, should be used with caution in patients receiving drugs known to prolong the QT interval (e.g. Class IA and III antiarrhythmics, tricyclic antidepressants, macrolides, antipsychotics) (see section 4.4 QT interval prolongation).</p><p><strong><em>Other relevant information</em></strong></p><p>In a pharmacokinetic interaction study, levofloxacin did not affect the pharmacokinetics of theophylline (which is a probe substrate for CYP1A2), indicating that levofloxacin is not a CYP1A2 inhibitor.</p><p><strong>Other forms of interactions</strong></p><p><strong><em>Food</em></strong></p><p>There is no clinically relevant interaction with food. Levon tablets may therefore be administered regardless of food intake.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>Pregnancy</em></strong></p><p>There are limited amount of data from the use of levofloxacin in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see section 5.3). However, in the absence of human data and due to the experimental data that suggest a risk of damage by fluoroquinolones to the weight-bearing cartilage of the growing organism, levofloxacin must not be used in pregnant women (see sections 4.3 and 5.3).</p><p><strong><em>Breast-feeding</em></strong></p><p>Levofloxacin is contraindicated in breast-feeding women. There is insufficient information on the excretion of levofloxacin in human milk; however other fluoroquinolones are excreted in breast milk. In the absence of human data and due to the experimental data that suggest a risk of damage by fluoroquinolones to the weight-bearing cartilage of the growing organism, levofloxacin must not be used in breast-feeding women (see sections 4.3 and 5.3).</p><p><strong><em>Fertility</em></strong></p><p>Levofloxacin caused no impairment of fertility or reproductive performance in rats.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Some undesirable effects (e.g. dizziness/vertigo, drowsiness, visual disturbances) may impair the patient&#39;s ability to concentrate and react, and therefore may constitute a risk in situations where these abilities are of special importance (e.g. driving a car or operating machinery).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The information given below is based on data from clinical studies in more than 8300 patients and on extensive post marketing experience.</p><p>Frequencies are defined using the following convention: very common (&ge;1/10), common (&ge;1/100 to &lt;1/10), uncommon (&ge;1/1,000 to &lt;1/100), rare (&ge;1/10,000 to &lt;1/1000), very rare (&lt;1/10,000), not known (cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p><strong>System organ class</strong></p></td><td style="vertical-align:top"><p><strong>Common (&ge;1/100 to &lt;1/10)</strong></p></td><td style="vertical-align:top"><p><strong>Uncommon (&ge;1/1,000 to &lt;1/100)</strong></p></td><td style="vertical-align:top"><p><strong>Rare (&ge;1/10,000 to &lt;1/1,000)</strong></p></td><td style="vertical-align:top"><p><strong>Not known (cannot be estimated from the available data)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Infections and infestations</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Fungal infection including Candida infection</p><p>Pathogen resistance</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Blood and lymphatic system disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Eosinophilia</p><p>Leukopenia</p></td><td style="vertical-align:top"><p>Neutropenia, Thrombocytopenia</p></td><td style="vertical-align:top"><p>Haemolytic anaemia, Pancytopenia</p><p>Agranulocytosis</p></td></tr><tr><td style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Angioedema</p><p>Hypersensitivity (see section 4.4)</p></td><td style="vertical-align:top"><p>Anaphylactic shock<sup>a</sup></p><p>Anaphylactoid shock<sup>a</sup>(see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Metabolism and nutrition disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Anorexia</p></td><td style="vertical-align:top"><p>Hypoglycaemia, particularly in diabetic patients (see section 4.4)</p></td><td style="vertical-align:top"><p>Hyperglycaemia</p><p>Hypoglycaemic coma (see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Psychiatric disorders</strong></p></td><td style="vertical-align:top"><p>Insomnia</p></td><td style="vertical-align:top"><p>Confusional state</p><p>Anxiety</p><p>Nervousness</p></td><td style="vertical-align:top"><p>Psychotic reactions (with e.g. hallucination, paranoia)</p><p>Depression</p><p>Agitation</p><p>Abnormal dreams</p><p>Nightmares</p></td><td style="vertical-align:top"><p>Psychotic disorders with self-endangering behaviour including suicidal ideation or suicide attempt</p><p>(see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td><td style="vertical-align:top"><p>Headache</p><p>Dizziness</p></td><td style="vertical-align:top"><p>Somnolence</p><p>Tremor</p><p>Dysgeusia</p></td><td style="vertical-align:top"><p>Convulsion (see section 4.3 and 4.4)</p><p>Paraesthesia</p></td><td style="vertical-align:top"><p>Peripheral sensory neuropathy (see section 4.4)</p><p>Peripheral sensory motor neuropathy (see section 4.4)</p><p>Parosmia including anosmia</p><p>Dyskinesia</p><p>Extrapyramidal disorder</p><p>Ageusia</p><p>Syncope</p><p>Benign intracranial hypertension</p></td></tr><tr><td style="vertical-align:top"><p><strong>Eye disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Visual disturbances such as blurred vision (see section 4.4)</p></td><td style="vertical-align:top"><p>Transient vision loss (see section 4.4), uveitis</p></td></tr><tr><td style="vertical-align:top"><p><strong>Ear and Labyrinth disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Vertigo</p></td><td style="vertical-align:top"><p>Tinnitus</p></td><td style="vertical-align:top"><p>Hearing loss</p><p>Hearing impaired</p></td></tr><tr><td style="vertical-align:top"><p><strong>Cardiac disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Tachycardia</p><p>Palpitation</p></td><td style="vertical-align:top"><p>Ventricular tachycardia, which may result in cardiac arrest</p><p>Ventricular arrhythmia and torsades de pointes (reported predominantly in patients with risk factors for QT prolongation), Electrocardiogram QT prolonged (see section 4.4 and 4.9)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Vascular disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Hypotension</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Dyspnoea</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Bronchospasm</p><p>Pneumonitis</p><p>allergic</p></td></tr><tr><td style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td><td style="vertical-align:top"><p>Diarrhoea</p><p>Vomiting</p><p>Nausea</p></td><td style="vertical-align:top"><p>Abdominal pain</p><p>Dyspepsia</p><p>Flatulence</p><p>Constipation</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Diarrhoea-haemorrhagic which in very rare cases may be indicative of enterocolitis, including pseudomembranous colitis (see section 4.4)</p><p>Pancreatitis</p></td></tr><tr><td style="vertical-align:top"><p><strong>Hepatobiliary disorders</strong></p></td><td style="vertical-align:top"><p>Hepatic enzyme increased (ALT/AST, alkaline phosphatase, GGT)</p></td><td style="vertical-align:top"><p>Blood bilirubin increased</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Jaundice and severe liver injury, including cases with fatal acute liver failure, primarily in patients with severe underlying diseases (see section 4.4)</p><p>Hepatitis</p></td></tr><tr><td style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong><sup>b</sup></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Rash</p><p>Pruritus</p><p>Urticaria</p><p>Hyperhidrosis</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Toxic epidermal necrolysis</p><p>Stevens-Johnson syndrome</p><p>Erythema multiforme</p><p>Photosensitivity reaction (see section 4.4)</p><p>Leukocytoclastic vasculitis</p><p>Stomatitis</p></td></tr><tr><td style="vertical-align:top"><p><strong>Musculoskeletal and connective tissue disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Arthralgia</p><p>Myalgia</p></td><td style="vertical-align:top"><p>Tendon disorder (see sections 4.3 and 4.4) including tendinitis (e.g. Achilles tendon)</p><p>Muscular weakness which may be of special importance in patients with myasthenia gravis (see section 4.4)</p></td><td style="vertical-align:top"><p>Rhabdomyolysis</p><p>Tendon rupture (e.g. Achilles tendon) (see sections 4.3 and 4.4)</p><p>Ligament rupture</p><p>Muscle rupture</p><p>Arthritis</p></td></tr><tr><td style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Blood creatinine increased</p></td><td style="vertical-align:top"><p>Renal failure acute (e.g. due to interstitial nephritis)</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Asthenia</p></td><td style="vertical-align:top"><p>Pyrexia</p></td><td style="vertical-align:top"><p>Pain (including pain in back, chest, and extremities)</p></td></tr></tbody></table><p><sup>a</sup>&nbsp;Anaphylactic and anaphylactoid reactions may sometimes occur even after the first dose</p><p><sup>b</sup>&nbsp;Mucocutaneous reactions may sometimes occur even after the first dose</p><p>Other undesirable effects which have been associated with fluoroquinolone administration include:</p><p>&bull; attacks of porphyria in patients with porphyria</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.</p><p><!--[if gte vml 1]><v:shapetype id="_x0000_t202" coordsize="21600,21600"
 o:spt="202" path="m,l,21600r21600,l21600,xe">
 <v:stroke joinstyle="miter"/>
 <v:path gradientshapeok="t" o:connecttype="rect"/>
</v:shapetype><v:shape id="Text_x0020_Box_x0020_3" o:spid="_x0000_s1026"
 type="#_x0000_t202" style='position:absolute;margin-left:22.65pt;margin-top:4.65pt;
 width:377.2pt;height:119.25pt;z-index:251658240;visibility:visible;
 mso-width-relative:margin;mso-height-relative:margin' o:gfxdata="UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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"/><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>To report any side effect(s):</strong></p><p> The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>o Fax: +966-11-205-7662</p><p>o Call NPC at +966-11-2038222, Exts: 2317-2356-2340.</p><p>o Reporting hotline: 19999</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p></td></tr></tbody></table></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>According to toxicity studies in animals or clinical pharmacology studies performed with supra-therapeutic doses, the most important signs to be expected following acute overdose of Levon tablets are central nervous system symptoms such as confusion, dizziness, impairment of consciousness, and convulsive seizures, increases in QT interval as well as gastro-intestinal reactions such as nausea and mucosal erosions.</p><p>CNS effects including confusional state, convulsion, hallucination, and tremor have been observed in post marketing experience.</p><p>In the event of overdose, symptomatic treatment should be implemented. ECG monitoring should be undertaken, because of the possibility of QT interval prolongation. Antacids may be used for protection of gastric mucosa. Haemodialysis, including peritoneal dialysis and CAPD, are not effective in removing levofloxacin from the body. No specific antidote exists.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: quinolone antibacterials, fluoroquinolones, ATC code: J01 MA12</p><p>Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class and is the S (-) enantiomer of the racemic active substance ofloxacin.</p><p><u>Mechanism of action</u></p><p>As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA-DNA-gyrase complex and topoisomerase IV.</p><p><u>PK/PD relationship</u></p><p>The degree of the bactericidal activity of levofloxacin depends on the ratio of the maximum concentration in serum C<sub>max&nbsp;</sub>or the area under the curve (AUC) and the minimal inhibitory concentration (MIC).</p><p><strong><em>Mechanism of resistance</em></strong></p><p>Resistance to levofloxacin is acquired through a stepwise process by target site mutations in both type II topoisomerases, DNA gyrase and topoisomerase IV. Other resistance mechanisms such as permeation barriers (common in&nbsp;<em>Pseudomonas aeruginosa</em>) and efflux mechanisms may also affect susceptibility to levofloxacin.</p><p><u>Cross-resistance between levofloxacin and other fluoroquinolones is observed. Due to the mechanism of action, there is generally no cross-resistance between levofloxacin and other classes of antibacterial agents</u>.</p><p><strong><em>Breakpoints</em></strong></p><p>The EUCAST recommended MIC breakpoints for levofloxacin, separating susceptible from intermediately susceptible organisms and intermediately susceptible from resistant organisms are presented in the below table for MIC testing (mg/L).</p><p><strong><em>EUCAST clinical MIC breakpoints for levofloxacin (version 2.0, 2012-01-01):</em></strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p><strong>Pathogen</strong></p></td><td style="vertical-align:top"><p><strong>Susceptible</strong></p></td><td style="vertical-align:top"><p><strong>Resistant</strong></p></td></tr><tr><td style="vertical-align:top"><p>Enterobacteriacae</p></td><td style="vertical-align:top"><p>&le;1 mg/L</p></td><td style="vertical-align:top"><p>&gt;2 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Pseudomonas spp.</em></p></td><td style="vertical-align:top"><p>&le;1 mg/L</p></td><td style="vertical-align:top"><p>&gt;2 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Acinetobacter spp.</em></p></td><td style="vertical-align:top"><p>&le;1 mg/L</p></td><td style="vertical-align:top"><p>&gt;2 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus spp.</em></p></td><td style="vertical-align:top"><p>&le;1 mg/L</p></td><td style="vertical-align:top"><p>&gt;2 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>S.pneumoniae&nbsp;<sup>1</sup></em></p></td><td style="vertical-align:top"><p>&le;2 mg/L</p></td><td style="vertical-align:top"><p>&gt;2 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus A,B,C,G</em></p></td><td style="vertical-align:top"><p>&le;1 mg/L</p></td><td style="vertical-align:top"><p>&gt;2 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>H.influenzae&nbsp;<sup>2,3</sup></em></p></td><td style="vertical-align:top"><p>&le;1 mg/L</p></td><td style="vertical-align:top"><p>&gt;1 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>M.catarrhalis</em><sup>3</sup></p></td><td style="vertical-align:top"><p>&le;1 mg/L</p></td><td style="vertical-align:top"><p>&gt;1 mg/L</p></td></tr><tr><td style="vertical-align:top"><p>Non-species related breakpoints<sup>4</sup></p></td><td style="vertical-align:top"><p>&le;1 mg/L</p></td><td style="vertical-align:top"><p>&gt;2 mg/L</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><sup>1</sup>&nbsp;The breakpoints for levofloxacin relate to high dose therapy.</p><p><sup>2</sup>&nbsp;Low-level fluoroquinolone resistance (ciprofloxacin MICs of 0.12-0.5 mg/l) may occur but there is no evidence that this resistance is of clinical importance in respiratory tract infections with&nbsp;<em>H. influenzae</em>.</p><p><sup>3</sup>&nbsp;Strains with MIC values above the susceptible breakpoint are very rare or not yet reported. The identification and antimicrobial susceptibility tests on any such isolate must be repeated and if the result is confirmed the isolate must be sent to a reference laboratory. Until there is evidence regarding clinical response for confirmed isolates with MIC above the current resistant breakpoint they should be reported resistant.</p><p><sup>4</sup>&nbsp;Breakpoints apply to an oral dose of 500 mg x 1 to 500 mg x 2 and an intravenous dose of 500 mg x 1 to 500 mg x 2.</p></td></tr></tbody></table><p>The prevalence of resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p><strong><u>Commonly susceptible species</u></strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-positive bacteria</u></p></td></tr><tr><td style="vertical-align:top"><p><em>Bacillus anthracis</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus aureus&nbsp;</em>methicillin-susceptible</p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus saprophyticus</em></p></td></tr><tr><td style="vertical-align:top"><p>Streptococci, group C and G</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus agalactiae</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pneumoniae</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pyogenes</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-negative bacteria</u></p></td></tr><tr><td style="vertical-align:top"><p><em>Eikenella corrodens</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Haemophilus influenzae</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Haemophilus para-influenzae</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Klebsiella oxytoca</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Moraxella catarrhalis</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Pasteurella multocida</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Proteus vulgaris</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Providencia rettgeri</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Anaerobic bacteria:</u></p></td></tr><tr><td style="vertical-align:top"><p><em>Peptostreptococcus</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Other</u></p></td></tr><tr><td style="vertical-align:top"><p>Chlamydophila<em>&nbsp;pneumoniae</em></p></td></tr><tr><td style="vertical-align:top"><p>Chlamydophila<em>&nbsp;psittaci</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Chlamydia trachomatis</em></p></td></tr><tr><td style="vertical-align:top"><p><em>LEGIONELLA PNEUMOPHILA</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Mycoplasma pneumoniae</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Mycoplasma hominis</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Ureaplasma urealyticum</em></p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Species for which acquired resistance may be a problem</u></strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-positive bacteria</u></p></td></tr><tr><td style="vertical-align:top"><p><em>Enterococcus faecalis</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus aureus&nbsp;</em>methicillin-resistant<sup>#</sup></p></td></tr><tr><td style="vertical-align:top"><p>Coagulase negative&nbsp;<em>Staphylococcus spp</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-negative bacteria</u></p></td></tr><tr><td style="vertical-align:top"><p><em>Acinetobacter baumannii</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Citrobacter freundii</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Enterobacter aerogenes</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Enterobacter cloacae</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Escherichia coli</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Klebsiella pneumoniae</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Morganella morganii</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Proteus mirabilis</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Providencia stuartii</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Pseudomonas aeruginosa</em></p></td></tr><tr><td style="vertical-align:top"><p><em>Serratia marcescens</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Anaerobic bacteria:</u></p></td></tr><tr><td style="vertical-align:top"><p><em>Bacteroides fragilis</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Inherent Resistant Strains</u></p></td></tr><tr><td style="vertical-align:top"><p><strong><em><u>Aerobics Gram-positive bacteria</u></em></strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Enterococcus faecium</em></p></td></tr></tbody></table><p><sup>#</sup>&nbsp;Methicillin-resistant&nbsp;<em>S.aureus&nbsp;</em>are very likely to possess co-resistance to fluoroquinolones, including levofloxcacin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Orally administered levofloxacin is rapidly and almost completely absorbed with peak plasma concentrations being obtained within 1-2 h. The absolute bioavailability is approximately 99-100 %.</p><p>Food has little effect on the absorption of levofloxacin.</p><p>Steady state conditions are reached within 48 hours following a 500 mg once or twice daily dosage regimen.</p><p><u>Distribution</u></p><p>Approximately 30 - 40 % of levofloxacin is bound to serum protein.</p><p>The mean volume of distribution of levofloxacin is approximately 100 l after single and repeated 500 mg doses, indicating widespread distribution into body tissues.</p><p><u>Penetration into tissues and body fluids</u></p><p>Levofloxacin has been shown to penetrate into bronchial mucosa, epithelial lining fluid, alveolar macrophages, lung tissue, skin (blister fluid), prostatic tissue and urine. However, levofloxacin has poor penetration into cerebro-spinal fluid.</p><p><u>Biotransformation</u></p><p>Levofloxacin is metabolised to a very small extent, the metabolites being desmethyl-levofloxacin and levofloxacin N-oxide. These metabolites account for &lt; 5 % of the dose excreted in urine. Levofloxacin is stereochemically stable and does not undergo chiral inversion.</p><p><u>Elimination</u></p><p>Following oral and intravenous administration of levofloxacin, it is eliminated relatively slowly from the plasma (t<sub>&frac12;</sub>: 6 - 8 h). Excretion is primarily by the renal route (&gt; 85 % of the administered dose).</p><p>The mean apparent total body clearance of levofloxacin following a 500 mg single dose was 175 +/-29.2 ml/min.</p><p>There are no major differences in the pharmacokinetics of levofloxacin following intravenous and oral administration, suggesting that the oral and intravenous routes are interchangeable.</p><p><u>Linearity</u></p><p>Levofloxacin obeys linear pharmacokinetics over a range of 50 to 1000 mg.</p><p><u>Special populations</u></p><p><em>Renal impairment</em></p><p>The pharmacokinetics of levofloxacin are affected by renal impairment. With decreasing renal function renal elimination and clearance are decreased, and elimination half-lives increased as shown in the table below:</p><p>Pharmacokinetics in renal insufficiency following single oral 500 mg dose</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p>Cl<sub>cr</sub>&nbsp;[ml/min]</p></td><td style="vertical-align:top"><p>&lt; 20</p></td><td style="vertical-align:top"><p>20 - 49</p></td><td style="vertical-align:top"><p>50 - 80</p></td></tr><tr><td style="vertical-align:top"><p>Cl<sub>R</sub>&nbsp;[ml/min]</p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>26</p></td><td style="vertical-align:top"><p>57</p></td></tr><tr><td style="vertical-align:top"><p>t<sub>1/2</sub>&nbsp;[h]</p></td><td style="vertical-align:top"><p>35</p></td><td style="vertical-align:top"><p>27</p></td><td style="vertical-align:top"><p>9</p></td></tr></tbody></table><p><strong><em>Elderly</em></strong></p><p><u>There are no significant differences in levofloxacin pharmacokinetics between young and elderly subjects, except those associated with differences in creatinine clearance.</u></p><p><u>Gender differences</u></p><p>Separate analysis for male and female subjects showed small to marginal gender differences in levofloxacin pharmacokinetics. There is no evidence that these gender differences are of clinical relevance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on conventional studies of single dose toxicity, repeated dose toxicity, carcinogenic potential and toxicity to reproduction and development.</p><p>Levofloxacin caused no impairment of fertility or reproductive performance in rats and its only effect on foetuses was delayed maturation as a result of maternal toxicity.</p><p>Levofloxacin did not induce gene mutations in bacterial or mammalian cells but did induce chromosome aberrations in Chinese hamster lung cells&nbsp;<em>in vitro</em>. These effects can be attributed to inhibition of topoisomerase II.&nbsp;<em>In vivo</em>&nbsp;tests (micronucleus, sister chromatid exchange, unscheduled DNA synthesis, dominant lethal tests) did not show any genotoxic potential.</p><p>Studies in the mouse showed levofloxacin to have phototoxic activity only at very high doses. Levofloxacin did not show any genotoxic potential in a photomutagenicity assay, and it reduced tumour development in a photocarcinogenicity study.</p><p>In common with other fluoroquinolones, levofloxacin showed effects on cartilage (blistering and cavities) in rats and dogs. These findings were more marked in young animals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Active Ingredient:</strong></p><p>Levofloxacin equivalent to 250, 500 &amp; 750 Levofloxacin</p><p><strong>&nbsp;</strong></p><p><strong>Excipients for Core:</strong></p><p>Hydroxypropyl Methylcellulose EP</p><p>Crospovidone NF</p><p>Silicified Microcrystalline Cellulose</p><p>Magnesium Stearate&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>Excipients for Film Coating:</strong></p><p>Polysorbate 80 EP</p><p>Titanium Dioxide EP</p><p>Purified Talc EP</p><p>Polyethylene Glycol MW 6000 EP</p><p>Hydroxypropyl Methylcellulose EP</p><p>Iron Oxide Yellow</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not Applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 2 Years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>- Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Blister Pack</p><p>Lidding material: Aluminum Foil</p><p>Forming Film: PVC/PE/PVDC</p><p>(PVC: polyvinyl chloride, PE: polyethylene, PVDC polyvinylidene chloride)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dammam Pharma
Saudi Arabia
Address: 1st industrial city, unit No.1, PO.BOX: 7137, Dammam 32234-4384
Phone: +966138216444
Fax: +966138216422
Email: regulatory-affairs@dammampharma.sa

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                November 2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>